FDAnews
www.fdanews.com/articles/108215-cubist-will-promote-astrazeneca-antibiotic

Cubist Will Promote AstraZeneca Antibiotic

July 2, 2008
Cubist Pharmaceuticals Inc. has signed an exclusive agreement to promote AstraZeneca Plc.’s antibiotic MERREM … which is used for treating appendicitis, peritonitis, complicated skin and skin structure infections, and pediatric bacterial meningitis.
Triangle Business Journal